Karolinska University Hospital / Karolinska Universitetssjukhuset

Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trial (2022) Saritas T, Reinartz S, Krueger T, Ketteler M, Liangos O, Labriola L, Stenvinkel P, et al. Journal article Bi-allelic loss-of-function variants in PPFIBP1 cause a neurodevelopmental disorder with microcephaly, epilepsy, and periventricular calcifications (2022) Rosenhahn E, O'Brien TJ, Zaki MS, Sorge I, Wieczorek D, Rostasy K, Vitobello A, et al. Journal article The Clinical Utility of Soluble Serum Biomarkers in Autoimmune Pancreatitis: A Systematic Review (2022) Dugic A, Gil CV, Mellenthin C, Vujasinovic M, Löhr JM, Mühldorfer S Journal article, Review article TREATMENT PATTERNS OF IDIOPATHIC INFLAMMATORY MYOPATHIES: RESULTS FROM AN INTERNATIONAL COHORT OF OVER 1,400 PATIENTS (2022) Aoude M, Gupta L, Hmamouchi I, Grignaschi S, Cavagna L, Kim M, R N, et al. Conference contribution HIGH FATIGUE SCORES IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: A MULTIGROUP COMPARATIVE STUDY FROM THE COVAD E-SURVEY. (2022) Grignaschi S, Cavagna L, Kim M, R N, Lilleker JB, Sen P, Agarwal V, et al. Conference contribution COVID-19 VACCINATION-RELATED ADVERSE EVENTS AMONG AUTOIMMUNE DISEASE PATIENTS: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASES (COVAD) STUDY (2022) Sen P, R N, Nune A, Lilleker JB, Agarwal V, Kardes S, Kim M, et al. Conference contribution Impact on follow-up strategies in patients with primary sclerosing cholangitis (2022) Bergquist A, Weismueller TJ, Levy C, Rupp C, Joshi D, Nayagam JS, Montano-Loza AJ, et al. Journal article Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment (2022) Reinoso-Segura M, Caballero-Velazquez T, Herrera P, Patriarca F, Fanin R, Bruno B, Einsele H, et al. Journal article Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT (2022) Machowicz R, Suarez F, Wiktor-Jedrzejczak W, Eikema DJ, De Wreede LC, Blok HJ, Isaksson C, et al. Journal article KEYNOTE-522: Neoadjuvant Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy Followed by Adjuvant Pembrolizumab vs Placebo for Early-stage Triple Negative Breast Cancer (2022) Mcarthur H, Cortes J, Dent R, Pusztai L, Kuemmel S, Bergh J, Denkert C, et al. Conference contribution